-
Retirement
Understand how the concept of time affects your financial plan
In the world of financial planning, numbers and calculations often take center stage, masking the profound impact of time on…
Read More » -
HEALTHCARE & MEDICARE
Solera Health partners with Calm and Lyra to launch behavioral health network
Digital health services company Solera Health launched its new behavioral health network on Tuesday, with Calm Health and Lyra Health…
Read More » -
HEALTHCARE & MEDICARE
Eli Lilly joins the chase for hot inflammation target, spending $100 million for rights to CSL drug
Eli Lilly has been looking for drugs to follow the path blazed by its best-selling cardiometabolic drugs. The pharmaceutical company's…
Read More » -
HEALTHCARE & MEDICARE
Healthcare’s obsession with artificial intelligence misses the point of nursing shortage
I was six years old when my sister was born, and I remember it vividly. In the hospital nursery, I…
Read More » -
Retirement
Write a Retirement Manifesto: A Declaration of the Life You Want
Retirement is not only a financial transition, but also a status transition. When your job no longer defines you, what…
Read More » -
HEALTHCARE & MEDICARE
Daffodil Health raises $16.3M for health plan management platform
Daffodil Health, an artificial intelligence platform for health plan management and claims processing, announced Tuesday that it has raised $16.3…
Read More » -
HEALTHCARE & MEDICARE
Ophthalmology Therapeutix is filing with FDA after wet AMD drug outperforms Regeneron's Eylea in Phase 3 testing
Oural Therapeutix's drug, being developed for wet age-related macular degeneration, is better at helping patients preserve their vision than Regeneron…
Read More » -
HEALTHCARE & MEDICARE
The future of pharmacy is now – health systems must take action to drive innovation, access and sustainability
Healthcare is at a critical inflection point: an aging population, breakthrough therapies, regulatory changes and technological advancements are combining to…
Read More » -
HEALTHCARE & MEDICARE
Disk Medicine rare disease drug rejected by FDA for faster regulatory review
Disc Medicine's attempt to launch a new treatment for a rare blood disorder with few treatment options has been derailed…
Read More »
